🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to transition patients who have been stable on...
Status
Completed
Location
Emory Clinic
Start Date
2015-09
Trial ID
NCT02560558
Treatments Being Tested
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
Belatacept is an experimental medication shown in clinical trials to have i...
Status
Terminated
Location
University of California, San Francisco
Start Date
2006-12
Trial ID
NCT00346151
Treatments Being Tested
* To determine the utility of novel blood-based immune monitoring tools (Al...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-02-11
Trial ID
NCT04177095
Treatments Being Tested
This will be a pilot study to investigate the use of belatacept (BMS) thera...
Status
Completed
Location
University of Maryland
Start Date
2012-03
Trial ID
NCT01496417
Treatments Being Tested
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
Currently looking for individuals that have received a kidney transplant, a...
Status
Terminated
Location
The Ohio State Universtiy Wexner Medical Center
Start Date
2014-04
Trial ID
NCT02134288
Treatments Being Tested
Background: Proteinuria develops in about 30% of kidney transplant recipien...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2015-10
Trial ID
NCT02327403
Treatments Being Tested
The neonatal pig islets will be used as donor culturing with our modified c...
Status
Completed
Location
Cell Transplantation and Gene Therapy Institute
Start Date
2013-07
Trial ID
NCT03162237
Treatments Being Tested
The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Status
Terminated
Location
University of Alabama
Start Date
2011-09
Trial ID
NCT01436305
Treatments Being Tested